Information about Paliseul Pharma
My details
*
*
*

Paliseul Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0874.952.569

VAT liability
Yes
Established
30-06-2005
Last balance sheet year
2024
Company size
Medium-sized 3,4 FTE
Commercial name
PHARMACIE VANHEMMENS
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Paliseul Pharma

2024 2023 2022 2021
Profit/Loss 180,201 -5 % 190,005 12 % 169,460 13 % 149,831
Equity 832,437 20 % 692,236 23 % 562,231 23 % 457,771
Gross margin 472,789 11 % 424,071 3 % 412,982 4 % 397,925
Employees 3.4 3.3 3.5 4.5

Publications from Paliseul Pharma

Date Publication
09-02-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
22-04-2015 Resignations, Appointments (FR)
01-12-2005 Rapport(s) (FR)
15-07-2005 Constitution (FR)

Frequently asked questions

What is the VAT number of Paliseul Pharma?
The VAT number of Paliseul Pharma is BE 0874.952.569.
Wat is the PEPPOL ID of Paliseul Pharma?
The PEPPOL ID of Paliseul Pharma is 0208:0874952569. Log in or start a free trial to see the full overview.
When was Paliseul Pharma founded?
Paliseul Pharma was founded on 30-06-2005.
What is the address of Paliseul Pharma?
The current registered office of Paliseul Pharma is located at Grand-Place 16, 6850 Paliseul.
When was the last time Paliseul Pharma filed their annual financial statements?
The most recent financial statements of Paliseul Pharma were filed on 24-06-2025.
How many employees does Paliseul Pharma have?
There are 3,4 FTEs working at Paliseul Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Paliseul Pharma?
At the time of its most recent financial statements, Paliseul Pharma did not publish any turnover figures. Paliseul Pharma reported a gross margin of €472,788.53.